Advanced search

Guidelines for the use of epoetin : have quality-of-life benefits been proven?

(2003) JOURNAL OF CLINICAL ONCOLOGY. 21(11). p.2223-2223
Author
Organization
Keywords
CHEMOTHERAPY, CANCER, TRIAL

Citation

Please use this url to cite or link to this publication:

Chicago
Bottomley, A, R Thomas, Kristel Van Steen, H Flechtner, and A de Graeff. 2003. “Guidelines for the Use of Epoetin : Have Quality-of-life Benefits Been Proven?” Journal of Clinical Oncology 21 (11): 2223–2223.
APA
Bottomley, A., Thomas, R., Van Steen, K., Flechtner, H., & de Graeff, A. (2003). Guidelines for the use of epoetin : have quality-of-life benefits been proven? JOURNAL OF CLINICAL ONCOLOGY, 21(11), 2223–2223.
Vancouver
1.
Bottomley A, Thomas R, Van Steen K, Flechtner H, de Graeff A. Guidelines for the use of epoetin : have quality-of-life benefits been proven? JOURNAL OF CLINICAL ONCOLOGY. 2003;21(11):2223–2223.
MLA
Bottomley, A, R Thomas, Kristel Van Steen, et al. “Guidelines for the Use of Epoetin : Have Quality-of-life Benefits Been Proven?” JOURNAL OF CLINICAL ONCOLOGY 21.11 (2003): 2223–2223. Print.
@article{5907723,
  author       = {Bottomley, A and Thomas, R and Van Steen, Kristel and Flechtner, H and de Graeff, A},
  issn         = {0732-183X},
  journal      = {JOURNAL OF CLINICAL ONCOLOGY},
  language     = {eng},
  number       = {11},
  pages        = {2223--2223},
  title        = {Guidelines for the use of epoetin : have quality-of-life benefits been proven?},
  url          = {http://dx.doi.org/10.1200/JCO.2003.99.208},
  volume       = {21},
  year         = {2003},
}

Altmetric
View in Altmetric
Web of Science
Times cited: